Global Health Cuts Are Coming: What Medicare Seniors Must Know Now

If you've been watching the news and wondering what America's new global health strategy has to do with your Medicare Advantage plan, you're asking exactly the right question. The short answer is: not directly, not immediately — but indirectly, and potentially over time, more than most people realize. Here's what's actually happening, why it matters to seniors, and what you can do to protect your coverage in the years ahead.

In September 2025, the U.S. government released what it calls the America First Global Health Strategy. This policy document outlines a fundamental shift in how the United States engages with other countries on health issues. Rather than continuing open-ended foreign health assistance programs, the U.S. is now signing formal bilateral agreements — called Memorandums of Understanding, or MOUs — with countries that receive American global health funding. These are five-year plans covering 2026 through 2030, and they come with a clear message: the U.S. will gradually reduce its financial support while each partner country commits to increasing its own domestic health spending. Think of it as the U.S. saying, 'We'll help you build the road, but you need to start paying for the maintenance.'

As of June 2026, the U.S. has signed these MOUs with multiple countries across Africa, Asia, and Latin America — regions where American global health dollars have historically funded HIV/AIDS treatment, tuberculosis programs, malaria prevention, and pandemic preparedness. The agreements are tracked by the Kaiser Family Foundation, which monitors State Department press releases, U.S. embassy announcements, and partner country Ministry of Health statements. Implementation of these agreements is slated for later in 2026, meaning the real-world effects on international health systems are just beginning to unfold.

So why should a 70-year-old Medicare beneficiary in Ohio or Florida care about health agreements signed with countries in sub-Saharan Africa? The connection runs through your pharmacy. A significant portion of the generic drugs dispensed through Medicare Part D plans — including medications for blood pressure, diabetes, cholesterol, and infections — are manufactured in India, which is one of the world's largest producers of generic pharmaceuticals. India's pharmaceutical sector depends heavily on active pharmaceutical ingredients sourced from other developing nations. When health infrastructure weakens in those countries, supply chain disruptions can follow. This isn't speculation — COVID-19 demonstrated exactly how fragile global drug supply chains can be when international health systems are stressed.

Data Snapshot: According to CMS.gov data, in 2025 there were approximately 4,800 Medicare Advantage plans available nationwide, with average monthly premiums ranging from $0 (for many HMO plans) to over $100 depending on the region and benefit structure. The average Medicare Part D standalone prescription drug plan premium in 2025 was approximately $46.50 per month, according to CMS enrollment and premium data. These figures matter because any upstream pressure on drug manufacturing costs — whether from domestic policy changes or international supply disruptions — can eventually show up in your plan's formulary changes or cost-sharing adjustments at the next Annual Enrollment Period.

Beyond drug supply chains, there's a second connection worth understanding: pandemic preparedness. The America First MOUs specifically address what's called Global Health Security, or GHS — the international systems designed to detect, report, and contain disease outbreaks before they become pandemics. Several of the bilateral agreements include language about outbreak preparedness and response. If partner countries struggle to maintain these systems as U.S. funding decreases, the early-warning infrastructure that helped the world identify COVID-19, Ebola, and mpox could weaken. For Medicare beneficiaries — who are statistically among the most vulnerable to severe outcomes from infectious disease — that's not an abstract concern. It's a direct health risk.

Now, let's be clear about what these global agreements do not affect, at least not directly. Your Medicare Part A hospital coverage, your Part B outpatient benefits, and your Medicare Advantage plan's network of doctors are all governed by domestic CMS rules and are funded through the Medicare Trust Fund and federal appropriations — not through the foreign aid budgets being restructured under the America First strategy. If you're enrolled in a Medicare Advantage plan in 2026, your benefits for this plan year are locked in. The Annual Enrollment Period that runs from October 15 through December 7 each year is your primary opportunity to make changes, and those changes take effect January 1 of the following year.

What seniors should be doing right now is treating this moment as a prompt to review their current coverage with fresh eyes. If you're on a Medicare Advantage plan that includes Part D drug coverage — called an MA-PD plan — pull out your plan's Evidence of Coverage document and look at your formulary. Specifically, check whether your most critical medications are on Tier 1 or Tier 2 (the lower-cost tiers), and whether your plan has any quantity limits or prior authorization requirements on those drugs. If your medications have shifted to higher tiers in recent years, that's a signal worth investigating during the next AEP. You can compare plans side-by-side at Medicare.gov's Plan Finder tool, which is free and doesn't require you to speak with a salesperson.

For beneficiaries who are enrolled in Original Medicare with a standalone Part D plan and a Medigap supplement, the calculus is slightly different. Medigap plans — also called Medicare Supplement Insurance — cover your out-of-pocket costs for Part A and Part B services, but they do not cover prescription drugs. Your drug coverage comes entirely from your standalone Part D plan. If drug costs rise due to supply chain pressures, your Part D plan's cost-sharing structure is where you'd feel it first. The good news is that the Inflation Reduction Act capped out-of-pocket drug costs for Medicare beneficiaries at $2,000 per year starting in 2025 — a significant protection that applies to all Part D enrollees regardless of which plan they're in.

State-level resources are often underused by Medicare beneficiaries navigating these kinds of broader policy shifts. Every state has a State Health Insurance Assistance Program, universally known as SHIP, that provides free, unbiased counseling from trained volunteers. These counselors can help you understand how national and global policy changes might affect your specific plan, walk you through your options during enrollment periods, and flag any changes to your plan's benefits before you're locked in for the year. To find your state's SHIP program, visit shiphelp.org or call 1-800-MEDICARE (1-800-633-4227).

It's also worth understanding the broader federal budget context. Global health assistance and Medicare are funded through entirely different congressional appropriations processes, but they share something important: both are subject to the same political environment in Washington. When federal budget priorities shift — as they clearly have with the America First strategy — it signals a broader philosophy about government spending on health. Seniors who pay attention to these signals tend to be better prepared when changes do arrive at their doorstep. The America First MOUs are a five-year commitment, meaning their full effects on international health systems — and any downstream effects on domestic drug markets or pandemic preparedness — will play out gradually through 2030.

One area where the connection between global health policy and Medicare becomes most tangible is in vaccine access. Medicare Part B covers certain vaccines — including flu shots, COVID-19 vaccines, and pneumococcal vaccines — at no cost to beneficiaries. Many of these vaccines are manufactured using global supply chains and tested through international clinical networks. The global health programs being restructured under the America First MOUs have historically supported vaccine distribution infrastructure in developing countries, which also serves as a testing ground for vaccine efficacy across diverse populations. A weakening of that infrastructure could slow future vaccine development timelines — though this is a long-term concern, not an immediate one.

For beneficiaries who are approaching Medicare eligibility — meaning you or a spouse are turning 65 in the next 12 months — the most important thing to know is that your Initial Enrollment Period (IEP) begins three months before your 65th birthday month and extends three months after it, for a total of seven months. Missing this window without having creditable employer coverage can result in permanent late enrollment penalties for Part B (10% per year of delay) and Part D (1% per month of delay). These penalties compound over time and can add hundreds of dollars per year to your premiums for the rest of your life. Don't let the noise of global policy debates distract from the very concrete deadlines that govern your own enrollment.

The bottom line for Medicare beneficiaries is this: the America First global health strategy is a real and significant policy shift that deserves attention, even if its effects on your Medicare plan are indirect and gradual. The wisest approach is to stay informed, review your coverage every year during AEP, use free resources like SHIP counselors and Medicare.gov's Plan Finder, and understand that your $2,000 annual out-of-pocket drug cap is a meaningful protection worth preserving. Global health and domestic Medicare policy are more connected than they appear — and seniors who understand that connection are better positioned to advocate for themselves when it matters most.